Biblio
“Abnormal epigenetic modification of lysosome and lipid regulating genes in Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251322955, 2025.
, “Alzheimer's disease-related cortical proteins modify the association of brain insulin signaling with cognitive decline.”, J Alzheimers Dis, vol. 104, no. 3, pp. 667-677, 2025.
, “ApoE ε4-dependent Alteration of CXCR3 CD127 CD4 T cells associates with elevated plasma neurofilament light chain in Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251320123, 2025.
, “Association of Alzheimer's disease biomarkers with low premorbid intellectual functioning in a multi-ethnic community-dwelling cohort: A cross-sectional study of HABS-HD.”, J Alzheimers Dis, p. 13872877251322966, 2025.
, “Associations of dietary protein and amino acid intakes with disability-adjusted life years for Alzheimer's disease in Japanese people.”, J Alzheimers Dis, p. 13872877251319535, 2025.
, “Baseline associations of office and ambulatory blood pressure monitoring with cognitive function and dementia prevalence.”, J Alzheimers Dis, p. 13872877251322400, 2025.
, “Brain-penetrant histone deacetylase inhibitor RG2833 improves spatial memory in females of an Alzheimer's disease rat model.”, J Alzheimers Dis, p. 13872877251314777, 2025.
, “Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting.”, J Alzheimers Dis, p. 13872877251323231, 2025.
, “Down syndrome and Alzheimer's disease: Oxidative stress in the neurodegenerative process.”, J Alzheimers Dis, p. 13872877251326291, 2025.
, “Dynamic PET imaging in patients with unilateral carotid occlusion shows lateralized cerebral hypoperfusion, but no amyloid binding.”, J Alzheimers Dis, p. 13872877251329593, 2025.
, “EEG biomarkers for Alzheimer's disease: A novel automated pipeline for detecting and monitoring disease progression.”, J Alzheimers Dis, p. 13872877251327754, 2025.
, “Factors associated with a healthy diet and willingness to change dietary behavior in older adults at increased risk of dementia.”, J Alzheimers Dis, p. 13872877251330296, 2025.
, “Increased risk of dementia associated with herpes simplex virus infections: Evidence from a retrospective cohort study using U.S. electronic health records.”, J Alzheimers Dis, p. 13872877251317228, 2025.
, “Increased unedited Alu RNA patterns found in cortex extracellular vesicles in Alzheimer's disease resemble hippocampus vasculature Alu RNA editing patterns but not cortex Alu RNA editing patterns.”, J Alzheimers Dis, p. 13872877241313054, 2025.
, “Interactive effects of ɛ4 status and vascular burden on white matter microstructural integrity in aging with and without neurocognitive decline.”, J Alzheimers Dis, p. 13872877251320660, 2025.
, “Iron chelation by oral deferoxamine treatment decreased brain iron and iron signaling proteins.”, J Alzheimers Dis, p. 13872877241313031, 2025.
, “Leptin, adiponectin, body mass index, and incident cognitive impairment.”, J Alzheimers Dis, p. 13872877251326060, 2025.
, “Lifespan of male and female APP/PS1 and APP mouse models of Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251325878, 2025.
, “Lipopolysaccharides from indirectly induce neuronal GSK3β-dependent synaptic defects and cause cognitive decline in a low-amyloid-β-concentration environment in Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251326879, 2025.
, “Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients.”, J Alzheimers Dis, p. 13872877241307870, 2025.
, “The potential impact of optimal blood pressure treatment intensity to reduce disparities in dementia between Black and White individuals.”, J Alzheimers Dis, p. 13872877241302506, 2025.
, “Semaglutide improves cognitive function and neuroinflammation in APP/PS1 transgenic mice by activating AMPK and inhibiting TLR4/NF-κB pathway.”, J Alzheimers Dis, p. 13872877251329439, 2025.
, “Sex-specific effects of apolipoprotein E ε4 genotype on longitudinal hippocampal atrophy in amnestic mild cognitive impairment over a 2-year evaluation period.”, J Alzheimers Dis, p. 13872877241313066, 2025.
, “White matter lesions rather than amyloid-β burden are associated with cognitive decline in Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251316516, 2025.
, “Acute Hyperglycemia Induced by Hyperglycemic Clamp Affects Plasma Amyloid-β in Type 2 Diabetes.”, J Alzheimers Dis, vol. 99, no. 3, pp. 1033-1046, 2024.
,